• LAST PRICE
    8.3500
  • TODAY'S CHANGE (%)
    Trending Up0.1400 (1.7052%)
  • Bid / Lots
    8.0000/ 1
  • Ask / Lots
    8.9800/ 1
  • Open / Previous Close
    8.2900 / 8.2100
  • Day Range
    Low 8.2000
    High 8.6100
  • 52 Week Range
    Low 6.5750
    High 17.5300
  • Volume
    381,488
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 8.21
TimeVolumeETNB
09:32 ET41708.56
09:34 ET2538.28
09:38 ET22718.28
09:39 ET1008.34
09:41 ET1008.29
09:43 ET7658.26
09:45 ET1258.22
09:48 ET7038.24
09:50 ET5008.25
09:52 ET14238.31
09:54 ET1008.315
09:56 ET1008.28
09:57 ET1248.3
09:59 ET7358.3
10:01 ET2528.32
10:03 ET8008.3
10:06 ET10368.34
10:08 ET3008.38
10:12 ET1008.36
10:15 ET41768.365
10:17 ET10248.37
10:21 ET3008.37
10:26 ET1008.38
10:28 ET5848.38
10:30 ET1008.38
10:32 ET1008.37
10:33 ET4458.385
10:35 ET5008.39
10:37 ET3008.37
10:39 ET3358.41
10:42 ET6008.425
10:44 ET27848.43
10:46 ET1988.44
10:48 ET4528.46
10:50 ET5008.47
10:51 ET5308.47
10:53 ET2008.44
10:55 ET3508.45
10:57 ET1008.4
11:00 ET3008.4
11:02 ET6008.38
11:04 ET7198.41
11:06 ET1008.39
11:09 ET6928.44
11:11 ET7698.42
11:13 ET2008.429
11:20 ET2278.42
11:22 ET3008.42
11:24 ET8218.45
11:26 ET2228.462
11:27 ET15008.5
11:29 ET5008.5
11:31 ET8008.5
11:33 ET25438.54
11:36 ET8218.515
11:38 ET3008.505
11:40 ET42718.56
11:42 ET4088.6
11:45 ET15208.6
11:47 ET7108.6
11:49 ET4858.59
11:51 ET18998.55
11:56 ET7008.565
11:58 ET2598.56
12:00 ET1008.55
12:02 ET5088.51
12:03 ET4658.52
12:05 ET4768.52
12:07 ET9808.5
12:09 ET10998.51
12:12 ET10008.51
12:14 ET9368.52
12:16 ET3008.52
12:18 ET10478.47
12:20 ET1008.49
12:21 ET13258.475
12:23 ET10578.445
12:25 ET107158.4
12:27 ET8008.43
12:30 ET9578.445
12:32 ET3008.41
12:36 ET14258.46
12:38 ET22448.44
12:39 ET21008.44
12:41 ET6668.49
12:43 ET1008.45
12:45 ET2008.45
12:48 ET17188.4
12:50 ET6178.41
12:52 ET10328.385
12:54 ET4568.375
12:56 ET6228.41
12:57 ET2008.41
12:59 ET3008.37
01:01 ET6708.37
01:03 ET1008.38
01:06 ET4308.38
01:08 ET6178.39
01:10 ET5008.38
01:12 ET1008.38
01:14 ET10368.34
01:15 ET5748.36
01:17 ET17838.345
01:21 ET1008.36
01:24 ET2008.38
01:26 ET3078.4
01:30 ET9008.36
01:33 ET3008.35
01:35 ET2008.35
01:37 ET4308.38
01:39 ET3008.37
01:42 ET2008.37
01:44 ET4008.36
01:46 ET3728.3467
01:48 ET3008.335
01:50 ET3288.36
01:51 ET7288.395
01:53 ET6008.38
01:55 ET5008.39
01:57 ET5008.41
02:00 ET49778.44
02:02 ET7188.435
02:04 ET95688.415
02:06 ET1008.44
02:09 ET3008.415
02:11 ET2008.38
02:13 ET1138.38
02:18 ET2418.35
02:20 ET5048.33
02:22 ET32558.3007
02:24 ET15008.35
02:26 ET1008.32
02:27 ET2418.35
02:29 ET34008.34
02:31 ET1008.335
02:33 ET1008.35
02:36 ET1008.345
02:38 ET4878.35
02:40 ET3588.36
02:42 ET1008.37
02:45 ET1008.37
02:47 ET2278.36
02:49 ET4008.35
02:51 ET7288.35
02:54 ET3678.345
02:56 ET6008.35
02:58 ET1008.34
03:00 ET1008.34
03:02 ET1008.35
03:03 ET21158.38
03:05 ET5008.35
03:07 ET2008.32
03:16 ET1008.31
03:18 ET1058.3399
03:20 ET1008.31
03:21 ET39778.35
03:23 ET4308.33
03:25 ET18558.34
03:27 ET11858.375
03:30 ET5918.4
03:32 ET2008.419
03:34 ET143278.34
03:36 ET5398.35
03:39 ET4008.38
03:41 ET21008.405
03:43 ET6008.4
03:45 ET70218.34
03:48 ET18208.3431
03:50 ET18478.35
03:52 ET30498.335
03:54 ET9678.35
03:56 ET15278.35
03:57 ET26218.34
03:59 ET816398.35
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesETNB
89Bio Inc
869.5M
-4.2x
---
United StatesCATX
Perspective Therapeutics Inc
884.7M
-9.6x
---
United StatesORKA
Oruka Therapeutics Inc
906.5M
-4.4x
---
United StatesAVBP
Arrivent Biopharma Inc
824.2M
-9.7x
---
United StatesERAS
Erasca Inc
796.7M
-3.1x
---
United StatesTERN
Terns Pharmaceuticals Inc
794.2M
-7.3x
---
As of 2024-09-17

Company Information

89bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG). Pegozafermin is engineered to protect against proteolysis and reduce renal clearance and optimize its potency, enabling the potential use of a lower dosage/dose. Pegozafermin has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone. It conducted a Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics (PK) of pegozafermin.

Contact Information

Headquarters
142 Sansome Street, Second FloorSan Francisco, CA, United States 94104
Phone
415-432-9270
Fax
302-655-5049

Executives

Independent Chairman of the Board of Director
Steven Altschuler
Chief Executive Officer, Director
Rohan Palekar
Chief Financial Officer
Ryan Martins
Chief Operating Officer
Francis Sarena
Chief Technical Operations Officer and Head of Quality
Quoc Le-Nguyen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$869.5M
Revenue (TTM)
$0.00
Shares Outstanding
105.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.01
EPS
$-1.97
Book Value
$5.75
P/E Ratio
-4.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.